Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

August 21, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Primary Biliary Cholangitis
Interventions
DRUG

Fenofibrate

Fenofibrate 200 mg/day

DRUG

Placebo

1 tablet/ day

DRUG

UDCA

UDCA 13-15mg/kg/day

Trial Locations (10)

Unknown

RECRUITING

The second hospital of Lanzhou University, Lanzhou

NOT_YET_RECRUITING

Sun Yat-sen Memorial Hospital, Guangzhou

RECRUITING

Jiangsu Province Hospital, Nanjing

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

RECRUITING

Nanjing Second Hospital, Nanjing

RECRUITING

Shengjing Hospital Affiliated to China Medical University, Shenyang

RECRUITING

Xijing Hospital, Xi'an

RECRUITING

Yan'an University Affiliated Hospital, Yan’an

RECRUITING

The Second Affiliated Hospital of Kunming Medical University, Kunming

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Han Ying

OTHER